Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Brochet

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Journal of the Neurological Sciences|February 7, 2018
Preliminary evidence of the cerebellar role on cognitive performances in clinically isolated syndromeAmandine Moroso, Aurélie Ruet, Delphine Lamargue-Hamel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administrationJoanna Mikita, Nadège Dubourdieu-Cassagno, Mathilde Sa Deloire, et al.
Presse Medicale (Paris, France : 1983)|December 31, 2017
[Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders]Pierre Krolak-Salmon, Laurent Letrilliart, Mathieu Ceccaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2022
Differential vulnerability of thalamic nuclei in multiple sclerosisSimon Blyau, Ismail Koubiyr, Manojkumar Saranathan, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Journal of the Neurological Sciences|March 11, 2020
Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosisJean-Christophe Ouallet, Françoise Radat, Alain Creange, et al.
The Journal of Urology|December 11, 2003
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled studyMarianne de Sèze, Laurent Wiart, Mathieu-Panchoa de Sèze, et al.
BMC Neurology|July 18, 2012
Brief International Cognitive Assessment for MS (BICAMS): international standards for validationRalph H B Benedict, Maria Pia Amato, Jan Boringa, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
British Journal of Clinical Pharmacology|September 10, 2021
Comparative effectiveness of dimethyl fumarate in multiple sclerosisPauline Bosco-Lévy, Marc Debouverie, Bruno Brochet, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Journal of the Neurological Sciences|February 7, 2018
Preliminary evidence of the cerebellar role on cognitive performances in clinically isolated syndromeAmandine Moroso, Aurélie Ruet, Delphine Lamargue-Hamel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administrationJoanna Mikita, Nadège Dubourdieu-Cassagno, Mathilde Sa Deloire, et al.
Presse Medicale (Paris, France : 1983)|December 31, 2017
[Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders]Pierre Krolak-Salmon, Laurent Letrilliart, Mathieu Ceccaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2022
Differential vulnerability of thalamic nuclei in multiple sclerosisSimon Blyau, Ismail Koubiyr, Manojkumar Saranathan, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Journal of the Neurological Sciences|March 11, 2020
Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosisJean-Christophe Ouallet, Françoise Radat, Alain Creange, et al.
The Journal of Urology|December 11, 2003
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled studyMarianne de Sèze, Laurent Wiart, Mathieu-Panchoa de Sèze, et al.
BMC Neurology|July 18, 2012
Brief International Cognitive Assessment for MS (BICAMS): international standards for validationRalph H B Benedict, Maria Pia Amato, Jan Boringa, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
British Journal of Clinical Pharmacology|September 10, 2021
Comparative effectiveness of dimethyl fumarate in multiple sclerosisPauline Bosco-Lévy, Marc Debouverie, Bruno Brochet, et al.
Pageof 12